NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 88 filers reported holding NEXTCURE INC in Q2 2020. The put-call ratio across all filers is 2.99 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $473,206 | -28.4% | 366,826 | -0.0% | 0.00% | -50.0% |
| Q2 2023 | $660,508 | +14.9% | 366,949 | -5.6% | 0.00% | +100.0% |
| Q1 2023 | $575,082 | +4.8% | 388,569 | -0.1% | 0.00% | -50.0% |
| Q4 2022 | $548,518 | -62.0% | 389,020 | -26.0% | 0.00% | -50.0% |
| Q3 2022 | $1,445,000 | -41.5% | 525,406 | +0.0% | 0.00% | -42.9% |
| Q2 2022 | $2,469,000 | -3.3% | 525,335 | -0.0% | 0.01% | +16.7% |
| Q1 2022 | $2,554,000 | -19.0% | 525,572 | +0.0% | 0.01% | 0.0% |
| Q4 2021 | $3,153,000 | -11.2% | 525,540 | -0.3% | 0.01% | -14.3% |
| Q3 2021 | $3,552,000 | -13.3% | 526,985 | +3.3% | 0.01% | -12.5% |
| Q2 2021 | $4,098,000 | +11952.9% | 510,283 | +16424.7% | 0.01% | – |
| Q4 2020 | $34,000 | +3300.0% | 3,088 | +3712.3% | 0.00% | – |
| Q3 2020 | $1,000 | -100.0% | 81 | -99.9% | 0.00% | -100.0% |
| Q2 2020 | $2,394,000 | – | 111,679 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| K2 PRINCIPAL FUND, L.P. | 1,581,311 | $4,186,000 | 0.48% |
| Sofinnova Investments, Inc. | 2,671,856 | $7,348,000 | 0.43% |
| Long Focus Capital Management, LLC | 556,105 | $1,529,000 | 0.15% |
| DAFNA Capital Management LLC | 187,696 | $516,000 | 0.14% |
| Orbimed Advisors | 2,711,013 | $7,455,000 | 0.14% |
| Sio Capital Management, LLC | 130,000 | $358,000 | 0.11% |
| FNY Investment Advisers, LLC | 48,000 | $132,000 | 0.09% |
| Privium Fund Management (UK) Ltd | 24,400 | $67,000 | 0.08% |
| Minerva Advisors LLC | 31,713 | $87,000 | 0.07% |
| Krensavage Asset Management, LLC | 31,298 | $86,000 | 0.03% |